5301 - 5350 of 7877 Results
Title
Year
-
RESTRICTEDTitle: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathologyJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1961End Page: 1965Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27523Citation Count: 41
- The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events2018OPENTitle: The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of eventsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 67Issue #:Start Page: 224End Page: 229Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.10.018Best OA location URL: https://europepmc.org/articles/pmc6287952?pdf=renderCitation Count: 29
- Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers2018OPENTitle: Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 15Issue #: 2Start Page: 232End Page: 244Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.08.012Best OA location URL: https://pure.eur.nl/files/48163974/Repub_115206_O-A.pdfCitation Count: 233
- Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies2018OPENTitle: Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathiesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 28Issue #: 4Start Page: 548End Page: 560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy365Best OA location URL: https://academic.oup.com/hmg/article-pdf/28/4/548/27636558/ddy365.pdfCitation Count: 56
- Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress2018OPENTitle: Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stressJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 144Issue #:Start Page: 19End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.10.013Best OA location URL: https://europepmc.org/articles/pmc6286225?pdf=renderCitation Count: 49
-
OPENTitle: Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-33921-xBest OA location URL: https://www.nature.com/articles/s41598-018-33921-x.pdfCitation Count: 89
- Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse Brain2018OPENTitle: Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse BrainJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 11Issue #: 5Start Page: 1156End Page: 1170Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2018.09.004Best OA location URL: http://www.cell.com/article/S2213671118303898/pdfCitation Count: 42
- Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease2018OPENTitle: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1760End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27487Best OA location URL: https://europepmc.org/articles/pmc6261681?pdf=renderCitation Count: 18
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference2018OPENTitle: Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage InferenceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-018-05892-0Best OA location URL: https://www.nature.com/articles/s41467-018-05892-0.pdfCitation Count: 343
-
OPENTitle: Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s DiseaseJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 212End Page: 224Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-018-0981-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-018-0981-y.pdfCitation Count: 16
- Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data2018OPENTitle: Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging DataJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00318Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00318/pdfCitation Count: 63
- Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 22018OPENTitle: Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2Journal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 44Issue #: 6Start Page: 1446End Page: 1459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11064-018-2650-4Best OA location URL: https://europepmc.org/articles/pmc6450775?pdf=renderCitation Count: 8
- 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease2018RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 9
- Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease2018OPENTitle: Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0282-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-018-0282-4Citation Count: 185
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://manuscript.elsevier.com/S1353802018304310/pdf/S1353802018304310.pdfCitation Count: 16
-
OPENTitle: Abstracts from the 50th European Society of Human Genetics Conference: PostersJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 26Issue #: S1Start Page: 113End Page: 819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41431-018-0247-7Best OA location URL: https://www.nature.com/articles/s41431-018-0247-7.pdfCitation Count: 4
- Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson’s disease patients OFF and ON medications2018OPENTitle: Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson’s disease patients OFF and ON medicationsJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 119Issue #:Start Page: 24End Page: 33Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2018.07.024Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2018.07.024Citation Count: 15
-
OPENTitle: Importance of low diagnostic Accuracy for early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1551End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27485Best OA location URL: https://europepmc.org/articles/pmc6544441?pdf=renderCitation Count: 84
-
RESTRICTEDTitle: Meta-analysis of amantadine efficacy for improving preclinical research reliabilityJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1555End Page: 1557Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27486Citation Count: 7
- Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options2018RESTRICTEDTitle: Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current optionsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 352Issue #:Start Page: 142End Page: 150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.12.014Citation Count: 20
-
RESTRICTEDTitle: Sleep disorders and Parkinson disease; lessons from geneticsJournal Name: Sleep Medicine ReviewsPublisher: Elsevier BVVol: 41Issue #:Start Page: 101End Page: 112Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smrv.2018.01.006Best OA location URL: http://escholarship.mcgill.ca/downloads/tb09j975fCitation Count: 33
- The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress2018OPENTitle: The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stressJournal Name: Redox BiologyPublisher: Elsevier BVVol: 19Issue #:Start Page: 62End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2018.07.021Best OA location URL: https://doi.org/10.1016/j.redox.2018.07.021Citation Count: 74
- Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches2018RESTRICTEDTitle: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New ApproachesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 29Issue #: 12Start Page: 3937End Page: 3966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548Best OA location URL: https://europepmc.org/articles/pmc7234797?pdf=renderCitation Count: 24
-
OPENTitle: Modulation of intracellular calcium signaling by microRNA-34a-5pJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-018-1050-7Best OA location URL: https://www.nature.com/articles/s41419-018-1050-7.pdfCitation Count: 28
- Regional vesicular acetylcholine transporter distribution in human brain: A [18F]fluoroethoxybenzovesamicol positron emission tomography study2018OPENTitle: Regional vesicular acetylcholine transporter distribution in human brain: A [18F]fluoroethoxybenzovesamicol positron emission tomography studyJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 526Issue #: 17Start Page: 2884End Page: 2897Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.24541Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/146604/1/cne24541.pdfCitation Count: 48
- Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients2018OPENTitle: Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patientsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-31988-0Best OA location URL: https://www.nature.com/articles/s41598-018-31988-0.pdfCitation Count: 19
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction2018RESTRICTEDTitle: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interactionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 121Issue #:Start Page: 120End Page: 130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018Citation Count: 31
-
RESTRICTEDTitle: Animal models of neurodegenerative diseasesJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 21Issue #: 10Start Page: 1370End Page: 1379Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41593-018-0236-8Best OA location URL: https://europepmc.org/articles/pmc6615039?pdf=renderCitation Count: 374
- CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorder2018OPENTitle: CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorderJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-018-0129-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-018-0129-5Citation Count: 11
-
OPENTitle: USP 14 inhibition corrects an in vivo model of impaired mitophagyJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201809014Best OA location URL: https://doi.org/10.15252/emmm.201809014Citation Count: 82
- Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)2018OPENTitle: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 8Issue #: 4Start Page: 517End Page: 527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181434Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181434?id=journal-of-parkinsons-disease%2Fjpd181434Citation Count: 21
- Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat2018OPENTitle: Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the ratJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0066-0Best OA location URL: https://www.nature.com/articles/s41531-018-0066-0.pdfCitation Count: 48
-
OPENTitle: Lewy body pathology in Alzheimer's disease: A clinicopathological prospective studyJournal Name: Acta Neurologica ScandinavicaPublisher: Hindawi LimitedVol: 139Issue #: 1Start Page: 76End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.13028Best OA location URL: https://doi.org/10.1111/ane.13028Citation Count: 36
-
OPENTitle: Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's DiseaseJournal Name: PROTEOMICSPublisher: WileyVol: 18Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201800108Best OA location URL: https://europepmc.org/articles/pmc6283072?pdf=renderCitation Count: 57
- Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders2018OPENTitle: Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative DisordersJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 320Issue #: 11Start Page: 1151End Page: 1151Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2018.12917Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2702872/jama_ossenkoppele_2018_pc_180007.pdfCitation Count: 324
-
OPENTitle: β2‐adrenoreceptor medications and risk of Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 5Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25341Best OA location URL: https://europepmc.org/articles/pmc6881195?pdf=renderCitation Count: 65
- Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK22018OPENTitle: Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK2Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 19Issue #: 9Start Page: 2784End Page: 2784Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms19092784Best OA location URL: https://www.mdpi.com/1422-0067/19/9/2784/pdf?version=1537093660Citation Count: 2
-
OPENTitle: Common and rare GCH1 variants are associated with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 73Issue #:Start Page: 231.e1End Page: 231.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.09.008Best OA location URL: https://europepmc.org/articles/pmc6251729?pdf=renderCitation Count: 28
-
RESTRICTEDTitle: An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in PrimatesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1619End Page: 1631Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27462Citation Count: 47
- Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests2018RESTRICTEDTitle: Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological TestsJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1750End Page: 1759Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.110Best OA location URL: https://europepmc.org/articles/pmc6261669?pdf=renderCitation Count: 45
- Modeling and prediction of clinical symptom trajectories in Alzheimer’s disease using longitudinal data2018OPENTitle: Modeling and prediction of clinical symptom trajectories in Alzheimer’s disease using longitudinal dataJournal Name: PLOS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 9Start Page: e1006376End Page: e1006376Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1006376Best OA location URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1006376&type=printableCitation Count: 121
- Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease2018OPENTitle: Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s diseaseJournal Name: PeerJPublisher: PeerJVol: 6Issue #:Start Page: e5539End Page: e5539Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7717/peerj.5539Best OA location URL: https://peerj.com/articles/5539.pdfCitation Count: 18
- Multi-objective particle swarm optimization for postoperative deep brain stimulation targeting of subthalamic nucleus pathways2018OPENTitle: Multi-objective particle swarm optimization for postoperative deep brain stimulation targeting of subthalamic nucleus pathwaysJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 15Issue #: 6Start Page: 066020End Page: 066020Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1088/1741-2552/aae12fBest OA location URL: https://europepmc.org/articles/pmc6424118?pdf=renderCitation Count: 34
- Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease2018OPENTitle: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric diseaseJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 21Issue #: 10Start Page: 1482End Page: 1492Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-018-0223-0Best OA location URL: https://europepmc.org/articles/pmc6334654?pdf=renderCitation Count: 87
- Amyloid oligomer interactions and polymorphisms: disease-relevant distinct assembly of α-synuclein and tau2018OPENTitle: Amyloid oligomer interactions and polymorphisms: disease-relevant distinct assembly of α-synuclein and tauJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 44Issue #: 1Start Page: 222End Page: 223Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41386-018-0204-8Best OA location URL: https://www.nature.com/articles/s41386-018-0204-8.pdfCitation Count: 1
- Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson's disease: Findings from a 5-year prospective study2018RESTRICTEDTitle: Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson's disease: Findings from a 5-year prospective studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 98End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.013Citation Count: 31
-
RESTRICTEDTitle: Repeated Spiral Drawings in Essential Tremor: a Possible Limb-Based Measure of Motor LearningJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12311-018-0974-xCitation Count: 5
- Antidepressant potential of metabotropic glutamate receptor mGlu2 and mGlu3 negative allosteric modulators2018OPENTitle: Antidepressant potential of metabotropic glutamate receptor mGlu2 and mGlu3 negative allosteric modulatorsJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 44Issue #: 1Start Page: 214End Page: 236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41386-018-0192-8Best OA location URL: https://www.nature.com/articles/s41386-018-0192-8.pdfCitation Count: 17
- Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease2018OPENTitle: Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-018-0596-zBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-018-0596-zCitation Count: 67
-
OPENTitle: Early detection of Parkinson’s disease through patient questionnaire and predictive modellingJournal Name: International Journal of Medical InformaticsPublisher: Elsevier BVVol: 119Issue #:Start Page: 75End Page: 87Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ijmedinf.2018.09.008Best OA location URL: https://arxiv.org/pdf/1810.01855Citation Count: 64